COVID-19 useful links 03 August 2020

First published: 27/05/2020 | Last updated: August 3rd, 2020

This page contains the latest COVID-19 related links as of  3rd August 2020. To access the full catalogue of addiction related COVID-19 resources collected since late March 2020 click here 

Compiled by Christine Goodair



American Psychiatry Association webpage of guidance from the government at both the federal and state levels, plus information about working with patients with substance use disorders

Newfoundland and Labrador Centre for Applied Health Research , Canada, Impacts of COVID-19 on people with pre-existing substance use and addictions – quick response report focusing on the impact of mitigation on non-COVID populations

PHE  COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol- updated  July 31st

PHE Operational advice for alcohol, drugs and nicotine in emergency accommodation for people experiencing rough sleeping

Royal College of Psychiatrists COVID-19: Guidance for clinicians

Social Care Institute for Excellence: COVID-19 guide for drug and alcohol residential rehab and detox services aims to provide specific and useful information for dealing with COVID-19

Substance Abuse and Mental Health Services Adminstration (SAMHSA) COVID-19 guidance and resources

Harm Reduction/ Treatment

A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: Harm Reduction Journal report

Addiction and Recovery Covid-19 Response Fund launched

Harm reduction innovations under lock-down discussed in SDF’s latest Drugs Uncut episode

UK Parliament Early Day Motion Treatment services during the COVID-19 outbreak

Canadian Centre on Substance Use and Addiction infographic ‘Coping with Stress, Anxiety, and Substance Use during Covid-19: How Animals Can Help’

Canadian Centre on Substance Use and Addiction infographic ‘COVID-19 and Impaired Driving Risks’

Canadian Centre on Substance Use and Addiction infographic ‘Virtual Care for Mental Health and Substance Use during COVID-19’

DrugReporter Harm Reduction Responses to COVID-19 in Europe: Regularly Updated Infopage

Greater Manchester Mental Health NHS Trust Library and Knowledge Service Covid-19 resources

International Drug Policy Consortium: Technical brief: Harm reduction for people who use drugs

ISAM – COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper

NHS Substance Misuse Provider Alliance: Practice examples of services adapting during Covid-19 to help eliminate BBV’s

NHS Substance Misuse Provider Alliance: Supervised Dispensing after COVID-19

NHS Scotland advice : Coronavirus (COVID-19) and drug use

NIAAA the US National Institute on Alcohol Abuse and Alcoholism: list of useful resources on Alcohol and Covid-19 for the public, clinicians, and researchers

Royal College of Psychiatrists COVID-19: Working vulnerable people

Royal College of Psychiatrists COVID-19: Support for patients and carers

UNODC Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemicclick here

News and Opinion

Talking Drugs:The Crisis behind Bars: Global Policy Responses to COVID-19 in Prisons

NHS Substance Misuse Provider Alliance: The NHS SMPA New Happy Hour campaign supports sensible alcohol consumption during the pandemic

NHS Substance Misuse Provider Alliance: Moving To A Digital Service During Lockdown – What Have We Learned?

The Lancet Public Health –Correspondence ‘Fetal alcohol spectrum disorders: preventing collateral damage from COVID-19’ Jonathan Sher

The Conversation Australia: Drive-in music festivals allow you to social distance. But what happens when you add drugs and alcohol?

Independent: : Coronavirus and drug addiction are both a public health crisis – but only one is being taken seriously –  Ian Hamilton -Voices

EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation

People with a dependency a hidden cost of lock-down Some of Australia’s most vulnerable have been at real risk, Dr Hester Wilson writes.

BMJ Editorials COVID-19 and alcohol—a dangerous cocktail

BMJ Blog Reducing alcohol harm during self-isolation needs a measured approach

Millions in UK smoking more amid COVID-19 crisis, study suggests

ADFAM Blog Adapting our support to families affected by a parent’s alcohol dependency in Swindon

People with substance use disorders face greater challenges during the COVID-19 pandemic –The Conversation US

Getting back on the beers after lockdown? Here’s what you should know

Collective Voice Blog: Two months into lockdown, what have we learned so far?

University of Bedfordshire: addiction researcher has warned that lockdown could reverse UK’s ten year drop in alcohol consumption


ADFAM: Families in Lockdown: The effects of the COVID-19 lockdown on the family and friends of someone with an alcohol, drug or gambling problem survey report

Bristol Drug Project: Researching During A Pandemic -working with the Universities of Bristol and Bath to find out how the Coronavirus pandemic has affected the lives of people who inject drugs in Bristol.

Drug and Alcohol Research Connections – May 2020 – latest news from NDARC, NDRI and NCETA, with a special coronavirus (COVID-19) focus in this issue

EMCDDA COVID-19: New study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

Global Drug Survey’s COVID19 survey impact on drug useinterim results

The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 4)

Changes Related to COVID-19 in the Illegal Drug Supply and Access to Services, and Resulting Health Harms (CCENDU Alert)

House of Commons Nitrous Oxide: Coronavirus Parliamentary Question asking the Secretary of State for the Home Department, what assessment has been made of the change in the level of the use of nitrous oxide during the covid-19 outbreak.

INPUD COVID-19 Survey Report 1: Health & Rights of People who Use Drugs in a COVID-19 Environment

London School of Economics  Illicit Drugs during Covid-19 -how has COVID-19 affected some of the most vulnerable people in society? LSE Research

Observatoire Français des Drogues et des Toxicomanies English summary of the 2nd OFDT-TREND bulletin examining changes caused by the COVID-19 pandemic and the lockdown measures in France to practices of drug users, drug services and drug trafficking

Pharmaceuticals Journal: Substance use disorder in the COVID-19 pandemic Systematic review of vulnerabilities and complications

Release: Impact of Coronavirus on Drug Purchases Survey

University of Oxford researchers studying the effect of smoking, nicotine and vaping on COVID-19 severity inking primary and clinical data for the assessment of associations between smoking status and the severity of coronavirus disease

The National Association for Children of Alcoholics report: ‘Covid So Far, Lockdown and the Lost Children’ reports rise in calls from children whose parents have started to drink again in lockdown

The Canadian Centre on Substance Use and Addiction: Boredom and Stress Drives Increased Alcohol Consumption during COVID-19: NANOS Poll Summary Report

The Canadian Centre on Substance Use and Addiction: Impacts of the COVID-19 Pandemic on People Who Use Substances: What we have heard

Australian National University report ‘Alcohol consumption during the COVID-19 period’ shows Australians are drinking alcohol more frequently during the COVID-19 pandemic than before.

National Drug and Alcohol Research Centre: Have COVID-19 restrictions affected needle and syringe program transactions in Tasmania

Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020

National Drug and Alcohol Research Centre Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study

UNODC Research Brief: COVID-19 and the drug supply chain: from production and trafficking to use

UNODC Research Brief COVID-19-related Trafficking of Medical Products as a Threat to Public Health

The SSA does not endorse nor guarantee the accuracy of the information in external sources or links, and accepts no responsibility or liability for any consequences arising from the use of such information

Every effort is made to maintain the accuracy of the information on the SSA website. However, things change all the time. If you discover any out-of-date links or if you know of other links that could be included, please let us know.